https://doi.org/10.1016/j.ajic.2014.05.029
R
Rosana Richtmann
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
55
Papers
2.1K
Citations
18
h-index
24
i10-index
Rosana Richtmann is an academic researcher. The author has contributed to research in topics: Vaccine Coverage and Hesitancy & Neonatal and Maternal Infections & Central Venous Catheters and Hemodialysis. The author has an h-index of 18, co-authored 47 publications.
ORCID: 0000-0002-3190-9642Papers by this author
worksInternational Nosocomial Infection Control Consortiu (INICC) report, data summary of 43 countries for 2007-2012. Device-associated module
2014 · American Journal of Infection Control · 311 citations
Brazilian guidelines for the management of candidiasis – a joint meeting report of three medical societies: Sociedade Brasileira de Infectologia, Sociedade Paulista de Infectologia and Sociedade Brasileira de Medicina Tropical
2013 · The Brazilian Journal of Infectious Diseases · 149 citations
https://doi.org/10.1016/j.bjid.2013.02.001
Brazilian recommendations on the safety and effectiveness of the yellow fever vaccination in patients with chronic immune-mediated inflammatory diseases
2019 · Advances in Rheumatology · 35 citations
https://doi.org/10.1186/s42358-019-0056-x
Respiratory syncytial virus outbreak in neonatal intensive care unit: Impact of infection control measures plus palivizumab use
2012 · Antimicrobial Resistance and Infection Control · 28 citations
https://doi.org/10.1186/2047-2994-1-16
Chronic medical conditions associated with invasive pneumococcal diseases in inpatients in teaching hospitals in São Paulo city: Estimating antimicrobial susceptibility and serotype-coverage of pneumococcal vaccines
2023 · The Brazilian Journal of Infectious Diseases · 7 citations
https://doi.org/10.1016/j.bjid.2023.102746
Expert review of global real-world data on COVID-19 vaccine booster effectiveness and safety during the omicron-dominant phase of the pandemic
2022 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.21541721
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat